|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Aimmune Therapeutics, Inc. (AIMT) |
|
|
$34.49 0.00 (0.00%) as of 4:30 Mon 10/12
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
63,299,000 |
| Market
Cap: |
2.18(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$34.49 - $34.49 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Societe Des Produits Nestle S.a. |
10% Owner |
– – • |
2020-10-13 |
4 |
B |
$34.50 |
$1,867,046,402 |
I/I |
54,117,287 |
23,408,817 |
1.5 |
- |
|
| Behar Gregory |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$270,480 |
D/D |
(7,840) |
0 |
|
- |
|
| Behar Gregory |
Director |
– • – |
2020-10-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,192) |
0 |
|
- |
|
| Bjerkholt Eric |
Chief Financial Officer |
• – – |
2020-10-13 |
4 |
D |
$34.50 |
$824,723 |
D/D |
(23,905) |
0 |
|
- |
|
| Haumann Brett K |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$459,299 |
D/D |
(13,313) |
0 |
|
- |
|
| Iwicki Mark T |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$270,480 |
D/D |
(7,840) |
0 |
|
- |
|
| Seltzer Stacey Denenberg |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$270,480 |
D/D |
(7,840) |
0 |
|
- |
|
| Enright Patrick G |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$270,480 |
D/D |
(7,840) |
0 |
|
- |
|
| Adelman Daniel C Md |
Chief Medical Officer |
• – – |
2020-10-13 |
4 |
D |
$34.50 |
$770,834 |
D/D |
(22,343) |
0 |
|
- |
|
| Falberg Kathryn E |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$270,480 |
D/D |
(7,840) |
0 |
|
- |
|
| Sheehy Douglas T. |
See Remarks |
• – – |
2020-10-13 |
4 |
D |
$34.50 |
$1,272,188 |
D/D |
(36,875) |
0 |
|
- |
|
| Oxtoby Andrew |
Chief Commercial Officer |
• – – |
2020-10-13 |
4 |
D |
$34.50 |
$698,625 |
D/D |
(20,250) |
0 |
|
- |
|
| Mcdade Mark |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$270,480 |
D/D |
(7,840) |
0 |
|
- |
|
| Dallas Jayson Donald Alexander |
President and CEO |
• • – |
2020-10-13 |
4 |
D |
$34.50 |
$3,079,125 |
D/D |
(89,250) |
0 |
|
- |
|
| Bjerkholt Eric |
Chief Financial Officer |
• – – |
2020-10-10 |
4 |
D |
$34.50 |
$959,273 |
D/D |
(27,805) |
0 |
|
- |
|
| Haumann Brett K |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$215,625 |
D/D |
(6,250) |
0 |
|
- |
|
| Iwicki Mark T |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$1,365,062 |
D/D |
(39,567) |
0 |
|
- |
|
| Seltzer Stacey Denenberg |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$352,625 |
D/D |
(10,221) |
0 |
|
- |
|
| Enright Patrick G |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$3,163,547 |
I/I |
(91,697) |
0 |
|
- |
|
| Enright Patrick G |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$2,434,355 |
D/D |
(70,561) |
0 |
|
- |
|
| Adelman Daniel C Md |
Chief Medical Officer |
• – – |
2020-10-10 |
4 |
D |
$34.50 |
$1,430,508 |
D/D |
(41,464) |
0 |
|
- |
|
| Falberg Kathryn E |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$2,411,343 |
I/I |
(69,894) |
0 |
|
- |
|
| Falberg Kathryn E |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$2,249,124 |
D/D |
(65,192) |
0 |
|
- |
|
| Sheehy Douglas T. |
See Remarks |
• – – |
2020-10-10 |
4 |
D |
$34.50 |
$1,637,025 |
D/D |
(47,450) |
0 |
|
- |
|
| Oxtoby Andrew |
Chief Commercial Officer |
• – – |
2020-10-10 |
4 |
D |
$34.50 |
$218,903 |
D/D |
(6,345) |
0 |
|
- |
|
268 Records found
|
|
Page 1 of 11 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
